Neurocognitive predictors of adherence to an online pain self-management program adjunct to long-term opioid therapy
- PMID: 37278690
- PMCID: PMC10526690
- DOI: 10.1080/13803395.2023.2221396
Neurocognitive predictors of adherence to an online pain self-management program adjunct to long-term opioid therapy
Abstract
Introduction: While pain self-management programs can significantly improve patient outcomes, poor adherence is common and the need for research on predictors of adherence has been noted. A potential, but commonly overlooked, predictor is cognitive function. Our aim, then, was to examine the relative influence of various cognitive functional domains on engagement with an online pain self-management program.
Method: A secondary analysis of a randomized controlled trial testing the impact of E-health (a 4-month subscription to the online Goalistics Chronic Pain Management Program) plus treatment as usual, relative to treatment as usual alone, on pain and opioid dose outcomes in adults receiving long-term opioid therapy of morphine equivalence dose ≥20 mg; 165 E-health participants who completed an on-line neurocognitive battery were included in this sub-analysis. A variety of demographic, clinical, and symptom rating scales were also examined. We hypothesized that better processing speed and executive functions at baseline would predict engagement with the 4-month E-health subscription.
Results: Ten functional cognitive domains were identified using exploratory factor analysis and the resultant factor scores applied for hypothesis testing. The strongest predictors of E-health engagement were selective attention, and response inhibition and speed domains. An explainable machine learning algorithm improved classification accuracy, sensitivity, and specificity.
Conclusions: The results suggest that cognition, especially selective attention, inhibitory control, and processing speed, is predictive of online chronic pain self-management program engagement. Future research to replicate and extend these findings seems warranted.
Clinicaltrials.gov registration number: NCT03309188.
Keywords: Chronic Pain Management Program; Pain; cognition; neuropsychology; opioid therapy.
Conflict of interest statement
Disclosure of Interest
Marian Wilson was a paid consultant for two grants from the NIH with Linda Ruehlman, Ph.D., the owner of the Goalistics company, to provide expertise to the program development and received no rights to the company, intellectual property, or profits. The remaining authors report no conflict of interest.
Figures

References
-
- Akhurst J, Lovell M, Peacock A, & Bruno R (2021). A systematic review and meta-analysis of cognitive performance among people with chronic use of opioids for chronic non-cancer pain. Pain Medicine, 22(4), 979–993. - PubMed
-
- Allegri N, Mennuni S, Rulli E, Vanacore N, Corli O, Floriani I, De Simone I, Allegri M, Govoni S, Vecchi T, Sandrini G, Liccione D, & Biagioli E (2019). Systematic review and meta-analysis on neuropsychological effects of long-term use of opioids in patients with chronic noncancer pain. Pain Practice, 19(3), 328–343. - PubMed
-
- Antepohl W, Kiviloog L, Andersson J, & Gerdle B (2013). Cognitive impairment in patients with chronic whiplash-associated disorder - A matched control study. NeuroRehabilitation, 18(4), 307–315. - PubMed
-
- Ataoğlu E, Tiftik T, Kara M, Tunç H, Ersöz M, & Akkuş S (2013). Effects of chronic pain on quality of life and depression in patients with spinal cord injury. Spinal Cord, 51(1), 23–26. - PubMed
-
- Baker KS, Gibson S, Georgiou-Karistianis N, Roth RM, & Giummarra MJ (2016). Everyday executive functioning in chronic pain: Specific deficits in working memory and emotion control, predicted by mood, medications, and pain interference. The Clinical Journal of Pain, 32(8), 673–680. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical